Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

New Strong Buy Stocks for June 4th


Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

BioCryst Pharmaceuticals BCRX: This company which is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections, has seen the Zacks Consensus Estimate for its next year earnings increasing 83.3% over the last 60 days.

BioCryst Pharmaceuticals, Inc. Price and Consensus

BioCryst Pharmaceuticals, Inc. Price and Consensus

BioCryst Pharmaceuticals, Inc. price-consensus-chart | BioCryst Pharmaceuticals, Inc. Quote

OptimizeRx OPRX: This company which provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, has seen the Zacks Consensus Estimate for its current year earnings increasing 27.5% over the last 60 days.

OptimizeRx Corp. Price and Consensus

OptimizeRx Corp. Price and Consensus

OptimizeRx Corp. price-consensus-chart | OptimizeRx Corp. Quote

Bridgewater Bancshares BWB: This company which provides personal and commercial banking products and services to commercial real estate investors, small business entrepreneurs and high-net-worth individuals, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.7% over the last 60 days.

Bridgewater Bancshares, Inc. Price and Consensus

Bridgewater Bancshares, Inc. Price and Consensus

Bridgewater Bancshares, Inc. price-consensus-chart | Bridgewater Bancshares, Inc. Quote

Palomar Holdings PLMR: This rapidly growing and profitable company focused on the provision of catastrophe insurance for personal and commercial property, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days.

Palomar Holdings, Inc. Price and Consensus

Palomar Holdings, Inc. Price and Consensus

Palomar Holdings, Inc. price-consensus-chart | Palomar Holdings, Inc. Quote

Ferrari RACE: This company which is engaged in designing, manufacturing and selling sports cars, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 day.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
BioCryst Pharmaceuticals, Inc. (BCRX): Free Stock Analysis Report
 
OptimizeRx Corp. (OPRX): Free Stock Analysis Report
 
Ferrari N.V. (RACE): Free Stock Analysis Report
 
Bridgewater Bancshares, Inc. (BWB): Free Stock Analysis Report
 
Palomar Holdings, Inc. (PLMR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Legal notice

Comments